EWPI (Emerging World Pharma) Revenue: $ Mil (TTM As of . 20)


What is Emerging World Pharma Revenue?

Emerging World Pharma EWPI -98.00% Revenue is $ Mil as of . 20.

Emerging World Pharma's revenue for the three months ended in . 20 was $0.00 Mil. Emerging World Pharma does not have enough years/quarters to calculate its revenue for the trailing twelve months (TTM) ended in . 20. Emerging World Pharma's Revenue per Share for the three months ended in . 20 was $0.00. Emerging World Pharma does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

Emerging World Pharma  (OTCPK:EWPI) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Emerging World Pharma Revenue Related Terms

Emerging World Pharma Revenue Historical Data

* Premium members only.

The historical data trend for Emerging World Pharma's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emerging World Pharma Revenue Chart

Emerging World Pharma Annual Data
Trend
Revenue

Emerging World Pharma Quarterly Data
Revenue

EWPI vs ENZB, AOXG: Revenue Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Emerging World Pharma's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Emerging World Pharma Revenue vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Emerging World Pharma's Revenue distribution charts can be found below:

* The bar in red indicates where Emerging World Pharma's Revenue falls into.


Emerging World Pharma Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of $ Mil mean?
Emerging World Pharma (EWPI) has a Revenue of $ Mil as of . 20. Revenue is the total amount a company generates as sales through its operations. View historical data on Emerging World Pharma and its competitors.
Is Emerging World Pharma's Revenue too high?
Emerging World Pharma's current Revenue is $ Mil.
How does Emerging World Pharma's Revenue compare to ENZB and AOXG?
Emerging World Pharma's Revenue of $ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Drug Manufacturers company?
A good Revenue depends on the Drug Manufacturers industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Emerging World Pharma and its competitors. Emerging World Pharma's current Revenue is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emerging World Pharma stock overvalued right now?
Emerging World Pharma (EWPI) has a current Revenue of $ Mil. The current Revenue is $ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Emerging World Pharma (EWPI), the current Revenue is $ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Emerging World Pharma Business Description

Address Block 11A, Pastoral Road, Sunyani, GHA, 20109
Emerging World Pharma Inc is an investor in generic based pharmaceutical companies manufacturing within developing nations.